Stratasys Ltd.
SSYSTechnologyNASDAQComputer Hardware · Last scanned Oct 24, 2026
Scan Results
Daily timeframeStratasys Ltd. provides connected polymer-based 3D printing solutions. The $595.6M market capitalization puts SSYS squarely in small-cap range for its industry. It offers range of 3D printing systems, including polyjet printers, fused deposition modeling (FDM) printers designed for prototyping, manufacturing tools, and production parts; PolyJet printers to print multiple materials including color printing in a single part build; pantone having validated colors, and multiple material properties; TechStyleTM, which allows 3D printing directly on different kinds of fabrics, enabling series productions in the fashion industry; Anatomy, which helps medical device companies optimize design throughout the product lifecycle; GelMatrix resin; TissueMatrix resin; BoneMatrix resin; and Digital Anatomy Creator to create different anatomical structures by customizing specific bio-mechanical properties and color.
Market Cap
$595.6M
Beta
1.99
P/E (TTM)
—
P/E (Fwd)
36.27
EPS (TTM)
$-1.34
EPS (Fwd)
$0.19
ROE
-13.4%
ROA
-4.0%
Cash
$212.5M
Total Debt
$25.4M
Free CF
$15.0M
52W Change
-43.3%
Annual Financials
Cash vs Debt
Where SSYS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, SSYS finished 16.27% below its 150-day moving average ($8.36) and 20.72% below its 200-day moving average ($8.83). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SSYS overbought or oversold?
At the October 20, 2026 close, SSYS's RSI(14) was 20.6, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $212.5M in cash and $25.4M in debt, SSYS maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Annual free cash flow of $15.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -13.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $651.5M (2022) to $551.1M (2025), a 15% decline worth watching.
Stratasys Ltd.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SSYS.